
Pharma Advantage at Risk as U.S. Prioritizes Domestic Drug Production
Advertisement Indian pharmaceutical companies may soon face significant challenges in the US market following former President Donald Trump’s executive orders to boost domestic drug manufacturing. The move is being seen as a potential game-changer for the …